Walleye Capital
RMD icon

Walleye Capital’s ResMed RMD Stock Holding History

Walleye Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Sell
1,600
-3,800
-70% -$788K ﹤0.01% 3145
2026
Q1 		$1.21M Sell
5,400
-200
-4% -$49.8K 0.01% 1901
2025
Q4 		$1.35M Buy
5,600
+1,700
+44% +$435K ﹤0.01% 2190
2025
Q3 		$1.07M Sell
3,900
-5,900
-60% -$1.61M ﹤0.01% 2039
2025
Q2 		$2.53M Sell
9,800
-3,600
-27% -$859K 0.01% 1338
2025
Q1 		$3M Buy
13,400
+5,900
+79% +$1.38M 0.01% 1137
2024
Q4 		$1.72M Sell
7,500
-14,200
-65% -$3.42M ﹤0.01% 1917
2024
Q3 		$5.3M Sell
21,700
-3,100
-13% -$693K 0.01% 1131
2024
Q2 		$4.75M Buy
24,800
+8,000
+48% +$1.62M 0.01% 1331
2024
Q1 		$3.33M Buy
16,800
+8,200
+95% +$1.5M 0.01% 1612
2023
Q4 		$1.48M Buy
8,600
+5,500
+177% +$845K ﹤0.01% 2030
2023
Q3 		$458K Buy
3,100
+500
+19% +$90.4K ﹤0.01% 2884
2023
Q2 		$568K Sell
2,600
-1,500
-37% -$334K ﹤0.01% 2338
2023
Q1 		$898K Buy
+4,100
New +$890K 0.01% 1236
2020
Q1 		– Sell
-100
Closed -$15K – 1530
2019
Q4 		$15K Buy
+100
New +$14.4K ﹤0.01% 1624

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Walleye Capital's RMD Position: Q2 2026 in Review

Walleye Capital increased its ResMed (RMD) stake by 2,483% in Q2 2026, buying an estimated $16.9M and bringing the position to 84,945 shares worth $16.6M. The position accounts for 0.06% of the portfolio, ranked #294.

Walleye Capital first reported a position in RMD in Q2 2019 and has held it in 12 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Walleye Capital held 84,945 shares of ResMed worth $16.6M as of Q2 2026.
  • Walleye Capital bought 81,656 ResMed shares in Q2 2026, an estimated $16.9M.
  • ResMed made up 0.06% of Walleye Capital's portfolio in Q2 2026, its #294 holding.
  • Walleye Capital first reported a position in ResMed in Q2 2019 and has held it in 12 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.